Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 Jan 29;30(1):26–31. doi: 10.1002/clc.2

Association of platelet‐monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non‐st elevation acute coronary syndromes

Song‐Zhao Zhang 1,✉, Ya‐Ping Jin 1, Guang‐Ming Qin 1, Jun‐Hong Wang 2
PMCID: PMC6653445  PMID: 17262778

Abstract

Background

Platelet‐monocyte aggregates (PMA) and C‐reactive protein (CRP) are increased in unstable coronary disease. The interrelation of PMA with platelet activation, systemic inflammation, and their association with markers of myocardial injury has not been studied extensively.

Hypothesis

The study was undertaken to evaluate the association of CRP, PMA, and cardiac troponin I (cTnI) in patients admitted with non‐ST elevation acute coronary syndromes (NSTE‐ACS).

Methods

In all, 69 consecutive patients with NSTE‐ACS, 58 patients with stable angina pectoris (SAP), and 46 control patients without coronary artery disease were selected; PMA, sP‐selectin, sCD40L inter leukin, (IL)‐6, CRP, and cTnI concentrations were measured in these patients at the time of admission. Patients with NSTE‐ACS were classified into two groups: those with troponin normal (cTnI < 0.06 ng/ml) and those with troponin elevation (cTnI ≥ 0.06 ng/ml). Their risk for clinical in‐hospital cardiac events (death and nonfatal myocardial infarction) was analyzed.

Results

Compared with SAP and control, patients with NSTE‐ACS exhibited higher levels of PMA, sP‐selectin, sCD40L, IL‐6, and CRP. All these parameters were found to be higher (p < 0.001 ) in patients with troponin elevation than in those with normal troponin. There was a significant relationship between PMA and CRP (r =0.628, p < 0.001) and cTnI (r = 0.557, p < 0.001) in patients with NSTE‐ACS. Logistic analysis further demonstrated that the presence of elevated PMA, CRP, and cTnI levels each confers and increases risk of future cardiac events.

Conclusions

Levels of PMA and CRP were significantly increased in patients with NSTE‐ACS, especially in those with troponin elevation. This increase is strongly related to the risk of in‐hospital cardiac events. A panel of PMA, CRP, and cTnI may provide important information additional to current laboratory data for the treatment of NSTE‐ACS. Copyright © 2007 Wiley Periodicals, Inc.

Keywords: acute coronary syndromes, platelet‐ monocyte aggregates, inflammation, troponin‐I

Full Text

The Full Text of this article is available as a PDF (176.4 KB).

REFERENCES

  • 1. Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365–372. [DOI] [PubMed] [Google Scholar]
  • 2. Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844–2850. [DOI] [PubMed] [Google Scholar]
  • 3. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135–1143. [DOI] [PubMed] [Google Scholar]
  • 4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C‐reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425–428. [DOI] [PubMed] [Google Scholar]
  • 5. McGregor L, Martin J, McGregor JL: Platelet‐leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosis. Front Biosci 2006; 11: 830–837. [DOI] [PubMed] [Google Scholar]
  • 6. Vandendries ER, Furie BC, Furie B: Role of P‐selectin and PSGL‐1 in coagulation and thrombosis. Thromb Haemost 2004; 92: 459–466. [DOI] [PubMed] [Google Scholar]
  • 7. Sarma J, Laan CA, Alam S, Jha A, Fox KA, et al: Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002; 105: 2166–2171. [DOI] [PubMed] [Google Scholar]
  • 8. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, et al: Circulating monocyte‐platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38: 1002–1006. [DOI] [PubMed] [Google Scholar]
  • 9. Faraday N, Braunstein JB, Heldman AW, Bolton ED, Chiles KA, et al: Prospective evaluation of the relationship between platelet‐leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes. Platelets 2004; 15: 9–14. [DOI] [PubMed] [Google Scholar]
  • 10. Freedman JE, Loscalzo J: Platelet‐monocyte aggregates: Bridging thrombosis and inflammation. Circulation 2002; 105: 2130–2132. [DOI] [PubMed] [Google Scholar]
  • 11. Wang JH, Qin GM, Zhang SZ, Jin Y‐P: Efficient measurement of platelet‐monocyte aggregates in whole blood by flow cytometry. J Chin Lab Med 2005; 28: 1288–1291. [Google Scholar]
  • 12. Myocardial infarction redefined—A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36: 959–968. [DOI] [PubMed] [Google Scholar]
  • 13. Grundy SM, Cleeman JI, Bairey Merz CN, Brewer HB Jr, Clark LT, et al: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227–239. [DOI] [PubMed] [Google Scholar]
  • 14. Morrow D, Rifai N, Sabatine M: Evaluation of the AccuTnI cardiac troponin assay for risk assessment in acute coronary syndromes. Clin Chem 2003; 49: 1396–1398. [DOI] [PubMed] [Google Scholar]
  • 15. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, et al: C‐reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998; 31: 1460–1465. [DOI] [PubMed] [Google Scholar]
  • 16. Jialal I, Devaraj S, Senthil K: C‐reactive protein: Risk marker or mediator in atherothrombosis? Hypertension 2004; 44: 6–11. [DOI] [PubMed] [Google Scholar]
  • 17. Ferrerirós ER, Boissonnet CP, Pizarro R, Garcı´a PF, Corrado G, et al: Independent prognostic value of elevated C‐reactive protein in unstable angina. Circulation 1999; 100: 1958–1963. [DOI] [PubMed] [Google Scholar]
  • 18. Heeschen C, Hamm CH, Bruemmer J, Simoons ML: Predictive value of C‐reactive protein and troponin T in patients with unstable angina: A comparative analysis. J Am Coll Cardiol 2000; 35: 1535–1542. [DOI] [PubMed] [Google Scholar]
  • 19. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L: Markers of myocardial damage and inflammation in relation to long‐term mortality in unstable coronary artery disease. N Engl J Med 2000; 343: 1139–1147. [DOI] [PubMed] [Google Scholar]
  • 20. Xiao ZH, Théroux P: Clopidogrel inhibits platelet‐leukocyte interactions and thrombin receptor agonist peptide‐induced platelet activation in patients with an acute coronary syndrome. J Am Coll Cardiol 2004; 43: 1982–1988. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES